For some time now, experts have predicted that if the cannabis industry expands at its current rate, the U.S. market alone will reach $20 Billion in revenues by 2020. But it turns out that one market is spinning off into a mega-industry of its own: according to a new estimate from cannabis industry analysts the Brightfield Group, the hemp-CBD market by itself could hit $22 billion by 2022. CBD, a non-psychoactive cannabinoid found in cannabis, has had a steady in popularity over the past couple of years and has jumped well beyond many expectations. Hemp-derived CBD is included in most products nowadays, including edibles and even treats for pets. Where it’s legal to do so, athletes use CBD oil for pain relief after a rough day at training, pet owners give CBD treats to their dogs and cats for de-stressing, and people take a swig of CBD-infused drinks for a quick energy boost. Active cannabis companies in the markets this week include PotNetwork Holdings, Inc.
Former CEO, Dr. Richard Goulding, assumes the new role of Chief Medical Officer, spearheading new product development and clinical testing of new proprietary products. Dr. Goulding will devote his time solely to this role, terminating any involvement with other entrepreneurial initiatives and affiliations, private or public, in the CBD industry. Dr. Goulding will focus on product development, in an effort to expand and enhance the Company’s offerings.
Kevin Hagen, new CEO, stated, “We want to thank Dr. Goulding for meeting the considerable demands in the past of being both our CEO, and Chairman of our medical advisory board. We are certain that as Chief Medical Officer, he will assist us in navigating the complexities we face with our new hemp-derived CBD product initiatives, as he works with our other advisory doctors, scientists and specialist legal counsel.” He added, “Since early 2017 we have been building our brand, consumer base, and product line. As we close 2018 and enter 2019, we plan to become a more robust company, with solid distribution and sales, upon which we can continue to build more brands and penetrate more markets. The achievement of long-term shareholder value is our goal, not short-term stock gains. We have our eyes fixed on getting to NASDAQ in the years ahead, which is a worthy goal for any early stage public company.”Read this and more news for POTN at: http://www.financialnewsmedia.com/news-potn